Head-to-head · Cost-Efficiency Index
LunaRx vs Next Vial
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
LunaRx
Shoppers who value simple flat-rate pricing and a no-cost-if-declined guarantee over named clinical credentials.
Visit LunaRxNext Vial
Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee.
Visit Next VialThe verdict
LunaRx and Next Vial tie on the Cost-Efficiency Index at 63/100, so neither wins outright on the numbers. For most shoppers we'd start with LunaRx (ranked #197, a hair above #198) — Shoppers who value simple flat-rate pricing and a no-cost-if-declined guarantee over named clinical credentials. But Next Vial is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs LunaRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | LunaRx | Next Vial |
|---|---|---|
| Cost-Efficiency Index | 63/100 | 63/100 |
| Semaglutide / mo | $149/mo (compounded) | $249/mo (all doses, compounded) |
| Tirzepatide / mo | $199/mo (compounded) | $249/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $2,988 |
| Tirzepatide / yr (modeled) | $2,388 | $2,988 |
| Coverage | Coverage not published | 49 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #197 | #198 |
LunaRx
63/100Where the value is
- Advertises simple, flat-rate pricing with no hidden fees
- '$0 if not approved' removes financial risk from a declined consult
- Founder is publicly named (Anamaria Galvan, RN) rather than fully anonymous leadership
The tradeoffs
- No named physician medical director -- only an RN founder is identified
- No named compounding pharmacy partner
Next Vial
63/100Where the value is
- Names its compounding pharmacy partner explicitly (Manifest Pharmacy, Greer, SC)
- Genuine LegitScript verification link found in the footer
- Explicit 44-state coverage list published in the FAQ
The tradeoffs
- Starting price is blended/generic ($249.97/mo) and not broken out by drug or dose tier anywhere public
- No individual medical director named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.